Claes H. Dohlman, MD, PhD, whose pioneering research at Massachusetts Eye and Ear and in the Department of Ophthalmology at Harvard Medical School (HMS) has forever changed the way conditions of the cornea are understood and treated, has been presented with the 2022 António Champalimaud Vision Award for his vast contributions to vision research. Dr. Dohlman, who was born in Uppsala, Sweden in 1922 and trained at the University of Lund and the Karolinska Institute in Stockholm, received the award along with fellow 2022 Champalimaud Laureate, Gerrit R. J. Melles, MD, PhD, founder of the Netherlands Institute for Innovative Ocular Surgery (NIIOS) and the Melles Cornea Clinic in Rotterdam. The award recipients were honored on September 15, 2022, during a ceremony held at the Champalimaud Centre for the Unknown in Lisbon, Portugal. The award carries a €1,000,000 ($1,000,000) prize that is shared among the winners to be used for furthering their research.
Cornea Research Pioneer Honored with Prestigious Award; Claes H. Dohlman, Widely Considered the Founder of Modern Cornea Science, Is One of Two Recipients of 2022 António Champalimaud Vision Award, Considered “Nobel Prize of Vision;” Award Comes With Shared $1,000,000 Prize for Continued Research
Login Or Register To Read Full Story